Drawing for BETTER MAGNESIUM.  BETTER BRAIN.

USPTO serial 99094918

BETTER MAGNESIUM. BETTER BRAIN.

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
DRUHAN, CONNOR M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BETTER MAGNESIUM. BETTER BRAIN.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth Oliner

Elizabeth Oliner Oliner Law345 Grove St., 2nd FloorSan Francisco, CA 94102United States

Goods and services

ClassDescriptionStatusFirst use
005Dietary and nutritional supplements containing magnesiumACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 17, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 17, 2026ALIEASSIGNED TO LIE—
Sep 14, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 10, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 10, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Apr 10, 2026CNSLSUSPENSION LETTER WRITTEN—
Feb 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 20, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2026NREVNOTICE OF REVIVAL - E-MAILED—
Feb 20, 2026PETGPETITION TO REVIVE-GRANTED—
Feb 20, 2026PROATEAS PETITION TO REVIVE RECEIVED—
Feb 19, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 19, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 4, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 22, 2025DOCKASSIGNED TO EXAMINER—
Oct 21, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 20, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 20, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance